Accu-Chek Combo in Young Patients

Evaluation of the Use of the Accu-Chek Combo System in Young Patients With Type 1 Diabetes

This is an open, prospective, descriptive study aiming to evaluate the change in treatment satisfaction of primary care givers of young children who use the Accu-Chek Combo System. Patients will routinely be scheduled and start their therapy with the Accu-Chek Combo System on visit 1. Twelve weeks later the final acquisition of data will occur. Diabetes Treatment Satisfaction Questionnaires (DTSQ) will be completed at baseline and after 12 weeks, a distinct acceptance questionnaires will be completed at final visit. In addition, Diabetes related therapeutic information will be collected and data about the use of the device components will be downloaded from the Accu-Chek Combo System

Inclusion Criteria:

• Diabetes Mellitus type 1
• Continuous Subcutaneous Insulin Infusion(CSII)therapy(for at least 6 months)
• Age below 6 years
• Planned and scheduled change to a Accu-Chek Combo System within the next 3 weeks at least
• Signing on an Inform Consent Form

Exclusion Criteria:

• Patient has been diagnosed with progressive/serious diseases that in judgment of the physician preclude successful completion of the observational period
• primary care giver not skilled enough to comment in a qualitative way